Home/Filings/4/0001209191-23-018303
4//SEC Filing

Dobak John 4

Accession 0001209191-23-018303

CIK 0001651944other

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 8:10 PM ET

Size

7.2 KB

Accession

0001209191-23-018303

Insider Transaction Report

Form 4
Period: 2023-03-09
Dobak John
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2023-03-09+56,407700,252 total
  • Sale

    Common Stock

    2023-03-13$3.26/sh1,559$5,082698,693 total
Footnotes (2)
  • [F1]The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan and the terms of a Transition Agreement, dated March 1, 2023, between the reporting person and the issuer. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, (i) three thirty-sixths (3/36) of the restricted stock units shall vest on June 5, 2023 and (ii) the remaining thirty-three thirty-sixths (33/36) shall vest in eleven (11) equal installments of three thirty-sixths (3/36) on the fifth day of each third month following June 5, 2023 until the final vesting date on March 5, 2026.
  • [F2]The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on June 25, 2020.

Issuer

DermTech, Inc.

CIK 0001651944

Entity typeother

Related Parties

1
  • filerCIK 0001787176

Filing Metadata

Form type
4
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 8:10 PM ET
Size
7.2 KB